- Home
- LIVN vs WRBY Comparison
LIVN vs WRBY Comparison
Compare LIVN & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIVN
- WRBY
- Stock Information
- Founded
- LIVN 1987
- WRBY 2010
- Country
- LIVN United Kingdom
- WRBY United States
- Employees
- LIVN N/A
- WRBY N/A
- Industry
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- WRBY Ophthalmic Goods
- Sector
- LIVN Health Care
- WRBY Health Care
- Exchange
- LIVN Nasdaq
- WRBY Nasdaq
- Market Cap
- LIVN 2.8B
- WRBY 3.0B
- IPO Year
- LIVN 1993
- WRBY 2021
- Fundamental
- Price
- LIVN $48.07
- WRBY $25.38
- Analyst Decision
- LIVN Buy
- WRBY Buy
- Analyst Count
- LIVN 7
- WRBY 11
- Target Price
- LIVN $67.14
- WRBY $22.00
- AVG Volume (30 Days)
- LIVN 458.1K
- WRBY 1.8M
- Earning Date
- LIVN 02-25-2025
- WRBY 02-26-2025
- Dividend Yield
- LIVN N/A
- WRBY N/A
- EPS Growth
- LIVN 759.09
- WRBY N/A
- EPS
- LIVN 0.43
- WRBY N/A
- Revenue
- LIVN $1,241,739,000.00
- WRBY $742,527,000.00
- Revenue This Year
- LIVN $10.10
- WRBY $16.92
- Revenue Next Year
- LIVN $5.43
- WRBY $13.10
- P/E Ratio
- LIVN $113.03
- WRBY N/A
- Revenue Growth
- LIVN 11.04
- WRBY 13.47
- 52 Week Low
- LIVN $43.15
- WRBY $11.35
- 52 Week High
- LIVN $64.48
- WRBY $27.10
- Technical
- Relative Strength Index (RSI)
- LIVN 48.18
- WRBY 54.84
- Support Level
- LIVN $48.23
- WRBY $24.65
- Resistance Level
- LIVN $49.46
- WRBY $26.55
- Average True Range (ATR)
- LIVN 1.12
- WRBY 1.17
- MACD
- LIVN 0.29
- WRBY -0.12
- Stochastic Oscillator
- LIVN 59.39
- WRBY 53.88
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.
About WRBY Warby Parker Inc.
Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.